A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes

Clinical trial NCT06972732 · RECRUITING

Trial details

NCT number: NCT06972732
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2025-06-11
Primary completion: 2026-10-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.